The Future of Clinical Trials: The Collaborative CTMS

What is a Collaborative CTMS?
Traditionally, clinical trial management systems (CTMS) have been designed as stand-alone applications for either research sites or for organizations that multi-site research, including CROs, SMOs, AMCs, provider networks and many others. However, it has become apparent in the research community that there is a need for collaboration between these two types of systems. Collaboration can be as simple as pushing study protocols from one system to another, all the way through a fully-integrated platform with complete bi-directional exchange of information. The greater the level of collaboration, the more benefits researchers will see.

Why is it Important?
Studies succeed or fail at the site. Without sites, it would be nearly impossible to get new drugs and devices to market. Improving communication between sites and sponsor organizations with collaborative CTMS applications is important because it benefits everybody involved in the research process.

Benefits Derived
A collaborative CTMS generates dozens of unique benefits for organizations using such a system. Streamlining the interaction between all of the parties involved in a clinical trial leads to faster turnarounds, more complete data and a better picture of what is taking place in any particular study at any particular location. With the cost of bringing new drugs to the market constantly increasing, it is critical to reduce costs wherever possible. Effective collaboration can help organizations save money while conducting research by eliminating wasted time, preventing costly errors and ensuring accurate billing and financial tracking.